UroGen Pharma Ltd. (NASDAQ:URGN) Q1 2026 Earnings Call Transcript May 6, 2026
UroGen Pharma Ltd. beats earnings expectations. Reported EPS is $-0.47, expectations were $-0.48244.
Operator: Good day, and thank you for standing by. Welcome to the UroGen Pharma Q1 2026 Results Earnings Call. [Operator Instructions] Please be advised that today’s conference call is being recorded. I would now like to hand the conference over to your first speaker today, Vincent Perrone, Senior Director of...
